ATX 12.0% 8.8¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-6

  1. 1,841 Posts.
    lightbulb Created with Sketch. 33
    Don’t forget they trialled 14 patients on 3 dose levels, so arguably the lower doses may not have moved the needle as much as the higher doses which is what 2a will look at - if the 3 continuers were on 400mg that that is extremely encouraging of itself.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
8.8¢
Change
-0.012(12.0%)
Mkt cap ! $24.13M
Open High Low Value Volume
12.0¢ 13.5¢ 8.6¢ $614.5K 5.826M

Buyers (Bids)

No. Vol. Price($)
1 122997 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 11000 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.